Technology ❯Biotechnology ❯Genetic Engineering

mRNA Technology

Genetic Engineering Cancer Treatment mRNA Technology Funding Cuts Treatment Clinical Trials Virology Cancer Care Infectious Diseases Medical Technology

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.

Scientists Use mRNA to Expose Hidden HIV in White Blood Cells

Tardigrade Protein Shows Potential to Protect Healthy Cells During Radiation Therapy